272 related articles for article (PubMed ID: 14614483)
1. Cancer robustness: tumour tactics.
Kitano H
Nature; 2003 Nov; 426(6963):125. PubMed ID: 14614483
[No Abstract] [Full Text] [Related]
2. Mechanisms of drug inhibition of signalling molecules.
Sebolt-Leopold JS; English JM
Nature; 2006 May; 441(7092):457-62. PubMed ID: 16724058
[TBL] [Abstract][Full Text] [Related]
3. Drug resistance modulation in the laboratory and the clinic.
Dalton WS
Semin Oncol; 1993 Feb; 20(1):64-9. PubMed ID: 8475411
[No Abstract] [Full Text] [Related]
4. Increasing attention.
NicNiocaill B; Williams SD; Gölitz P
ChemMedChem; 2008 Jan; 3(1):3-5. PubMed ID: 18172911
[No Abstract] [Full Text] [Related]
5. Introduction to resistance to anticancer agents.
Kruh GD
Oncogene; 2003 Oct; 22(47):7262-4. PubMed ID: 14576836
[No Abstract] [Full Text] [Related]
6. Molecular imaging as a tool for personalized and targeted anticancer therapy.
McLarty K; Reilly RM
Clin Pharmacol Ther; 2007 Mar; 81(3):420-4. PubMed ID: 17339871
[No Abstract] [Full Text] [Related]
7. The convergence of cancer prevention and therapy in early-phase clinical drug development.
Abbruzzese JL; Lippman SM
Cancer Cell; 2004 Oct; 6(4):321-6. PubMed ID: 15488755
[TBL] [Abstract][Full Text] [Related]
8. BMS and Exelixis target tumor suppression pathways.
Expert Rev Anticancer Ther; 2001 Aug; 1(2):167. PubMed ID: 12113021
[No Abstract] [Full Text] [Related]
9. Cancer stem cells: a step toward the cure.
Boman BM; Wicha MS
J Clin Oncol; 2008 Jun; 26(17):2795-9. PubMed ID: 18539956
[No Abstract] [Full Text] [Related]
10. Tumour-targeted drug and gene delivery: principles and concepts.
Cassidy J; Schätzlein AG
Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893
[TBL] [Abstract][Full Text] [Related]
11. [Principles of chemotherapy of neoplastic diseases in children].
Matysiak M; Ochocka M
Pediatr Pol; 1982 Dec; 57(12):1099-105. PubMed ID: 7182789
[No Abstract] [Full Text] [Related]
12. [Drug therapy of cancer].
Brux Med; 1974 Oct; 54(10):583-92. PubMed ID: 4434239
[No Abstract] [Full Text] [Related]
13. New insights on oxidative stress in cancer.
Visconti R; Grieco D
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):240-5. PubMed ID: 19333869
[TBL] [Abstract][Full Text] [Related]
14. Signal transduction pathways in cancer development and as targets for cancer prevention.
Bode AM; Dong Z
Prog Nucleic Acid Res Mol Biol; 2005; 79():237-97. PubMed ID: 16096030
[No Abstract] [Full Text] [Related]
15. The tumour microenvironment: a novel target for cancer therapy.
Hanna E; Quick J; Libutti SK
Oral Dis; 2009 Jan; 15(1):8-17. PubMed ID: 18992016
[TBL] [Abstract][Full Text] [Related]
16. Targeted cancer therapy.
Sawyers C
Nature; 2004 Nov; 432(7015):294-7. PubMed ID: 15549090
[TBL] [Abstract][Full Text] [Related]
17. [Molecular mechanism of cell death induced by chemotherapeutic agents].
Saya H
Brain Nerve; 2009 Jul; 61(7):843-7. PubMed ID: 19618862
[TBL] [Abstract][Full Text] [Related]
18. Drugging the cancer genome: new challenges of infrequent and combinatorial targets.
Workman P
Curr Opin Investig Drugs; 2007 Jun; 8(6):445-6. PubMed ID: 17621872
[No Abstract] [Full Text] [Related]
19. Is there a case for selectively promiscuous anticancer drugs?
Fernández A; Crespo A; Tiwari A
Drug Discov Today; 2009 Jan; 14(1-2):1-5. PubMed ID: 19038361
[TBL] [Abstract][Full Text] [Related]
20. High-content assays in oncology drug discovery: opportunities and challenges.
Mouchet EH; Simpson PB
IDrugs; 2008 Jun; 11(6):422-7. PubMed ID: 18509783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
